Joshua Wang
Principal investigator, leads PATHOVAX LLC.
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$1.8MFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $1.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 6, 2020 | NSF | SBIR Phase II SBIR Phase II: Anti-Tumor Immune Redirectors (AIRs) for cancer treatment | $1.4M | PATHOVAX LLC |
| 2018 | NSF | SBIR Phase I SBIR Phase I: Anti-Tumor Immune Redirectors (AIRs) for cancer treatment | $225K | PATHOVAX LLC |
| Dec 19, 2017 | NSF | SBIR Phase I SBIR Phase I: Anti-Tumor Immune Redirectors (AIRs) for cancer treatment | $225K | PATHOVAX LLC |
Peer ranks
Federal funding#1,167
Awards as PI#822
Patents#273
Companies
- PATHOVAX LLCLeads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.